Progressive Multifocal Leukoencephalopathy: Clinical Trials

1 trial for Progressive Multifocal Leukoencephalopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow Progressive Multifocal Leukoencephalopathy: new trials by email Literature Review of Progressive Multifocal Leukoencephalopathy trials Research Report on Progressive Multifocal Leukoencephalopathy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Explore the Effect of Mefloquine in Participants With Progressive Multifocal Leukoencephalopathy (PML)
mefloquine - Progressive Multifocal Leukoencephalopathy
Phase 1 / Phase 2TerminatedBiogen372009-01-012014-07-31

Narrower conditions

Central Nervous System Diseases (1)  ·  Leukoencephalopathy, Progressive Multifocal (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Infections (1)  ·  Central Nervous System Viral Diseases (1)  ·  DNA Virus Infections (1)  ·  Demyelinating Diseases (1)  ·  Encephalitis (1)  ·  Encephalitis, Viral (1)  ·  Infections (1)  ·  Infectious Encephalitis (1)  ·  Leukoencephalopathies (1)  ·  Nervous System Diseases (1)  ·  Neuroinflammatory Diseases (1)  ·  Polyomavirus Infections (1)  ·  Slow Virus Diseases (1)  ·  Virus Diseases (1)

Interventions

Mefloquine (1)

Sponsors

Biogen (1)

Countries

Brazil (1)  ·  Germany (1)  ·  Italy (1)  ·  Spain (1)  ·  United States (1)

Results publications

PMID 23733308